HOONMO KOO to Enterocolitis, Pseudomembranous
This is a "connection" page, showing publications HOONMO KOO has written about Enterocolitis, Pseudomembranous.
Connection Strength
2.130
-
Non-toxigenic Clostridium difficile to prevent recurrent C. difficile infection. Evid Based Med. 2016 Apr; 21(2):67.
Score: 0.471
-
A hospital-based study of the clinical characteristics of Clostridium difficile infection in children. Pediatr Infect Dis J. 2014 Sep; 33(9):924-8.
Score: 0.429
-
Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol. 2014 Jun; 35(6):667-73.
Score: 0.418
-
Clostridium difficile: an emerging pathogen in children. Discov Med. 2012 Aug; 14(75):105-13.
Score: 0.371
-
Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs. 2010 Jul; 19(7):825-36.
Score: 0.321
-
Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication. Gut Liver. 2016 Mar; 10(2):250-4.
Score: 0.119